These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 9444572

  • 1. Benzodiazepine-GABAA receptor complex ligands in two models of anxiety.
    Nazar M, Jessa M, Płaźnik A.
    J Neural Transm (Vienna); 1997; 104(6-7):733-46. PubMed ID: 9444572
    [Abstract] [Full Text] [Related]

  • 2. The role of the hippocampus and 5-HT/GABA interaction in the central effects of benzodiazepine receptor ligands.
    Nazar M, Siemiatkowski M, Członkowska A, Sienkiewicz-Jarosz H, Płaźnik A.
    J Neural Transm (Vienna); 1999; 106(5-6):369-81. PubMed ID: 10443544
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
    Savić MM, Obradović DI, Ugresić ND, Cook JM, Sarma PV, Bokonjić DR.
    Psychopharmacology (Berl); 2005 Jul; 180(3):455-65. PubMed ID: 15719222
    [Abstract] [Full Text] [Related]

  • 6. The anxiolytic-like effect of rutin in rats involves GABAA receptors in the basolateral amygdala.
    Hernandez-Leon A, González-Trujano ME, Fernández-Guasti A.
    Behav Pharmacol; 2017 Jun; 28(4):303-312. PubMed ID: 28145981
    [Abstract] [Full Text] [Related]

  • 7. Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies.
    Jones GH, Schneider C, Schneider HH, Seidler J, Cole BJ, Stephens DN.
    Psychopharmacology (Berl); 1994 Mar; 114(2):191-9. PubMed ID: 7838907
    [Abstract] [Full Text] [Related]

  • 8. Bidirectional effects of benzodiazepine binding site ligands in the passive avoidance task: differential antagonism by flumazenil and beta-CCt.
    Savić MM, Obradović DI, Ugresić ND, Cook JM, Yin W, Bokonjić DR.
    Behav Brain Res; 2005 Mar 30; 158(2):293-300. PubMed ID: 15698896
    [Abstract] [Full Text] [Related]

  • 9. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test.
    Barbalho CA, Nunes-de-Souza RL, Canto-de-Souza A.
    Brain Res; 2009 Apr 24; 1267():65-76. PubMed ID: 19268657
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling.
    Klodzinska A, Tatarczyńska E, Chojnacka-Wójcik E, Nowak G, Cosford ND, Pilc A.
    Neuropharmacology; 2004 Sep 24; 47(3):342-50. PubMed ID: 15275823
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacological modulation of the diazepam-insensitive recombinant gamma-aminobutyric acidA receptors alpha 4 beta 2 gamma 2 and alpha 6 beta 2 gamma 2.
    Knoflach F, Benke D, Wang Y, Scheurer L, Lüddens H, Hamilton BJ, Carter DB, Mohler H, Benson JA.
    Mol Pharmacol; 1996 Nov 24; 50(5):1253-61. PubMed ID: 8913357
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Study of the modulatory activity of BZ (omega) receptor ligands on defensive behaviors in mice: evaluation of the importance of intrinsic efficacy and receptor subtype selectivity.
    Griebel G, Perrault G, Sanger DJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan 24; 23(1):81-98. PubMed ID: 10368858
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
    Jastrzębska-Więsek M, Siwek A, Partyka A, Kubacka M, Mogilski S, Wasik A, Kołaczkowski M, Wesołowska A.
    Neuropharmacology; 2014 Oct 24; 85():253-62. PubMed ID: 24905144
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.